NDC directory

Colony Stimulating Factor-1 Receptor Blockers list

Every FDA-approved prescription drug the FDA NDC directory tags with the Colony Stimulating Factor-1 Receptor Blocker [EPC] class, with brand names and DEA schedules.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

RUN IT IN RIVVI

Map Niktimvo and your other top fills to their generics

Rivvi lists each brand, its generics in RxNorm, and the brands with no generic.

Map my fills

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

2M+ interactions500K+ patientsHIPAA BAA

The FDA NDC directory lists 1 single-ingredient drug in this class: axatilimab.

Colony Stimulating Factor-1 Receptor Blockers (1)

Colony Stimulating Factor-1 Receptor Blockers: FDA Colony Stimulating Factor-1 Receptor Blocker class
DrugBrand namesTypeNDC listingsDEA schedule
AxatilimabNiktimvoSingle ingredient4Not controlled

FDA established pharmacologic class: Colony Stimulating Factor-1 Receptor Blocker [EPC].

Ask Rivvi

Ask about this drug class.

Opens a workspace. Rivvi explains the public drug-class record. It does not give dosing or medical advice.

Questions

What drugs are Colony Stimulating Factor-1 Receptor Blockers?

The FDA NDC directory lists 1 single-ingredient drug in this class: axatilimab.

Where does this list come from?

From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.

Related

RUN IT IN RIVVI

Map Niktimvo and your other top fills to their generics

Rivvi lists each brand, its generics in RxNorm, and the brands with no generic.

Map my fills

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

2M+ interactions500K+ patientsHIPAA BAA

Try it on your own data today.

Free to start. Most teams are using it the same day.